INOTEK PHARMACEUTICALS CORP's ticker is ITEK and the CUSIP is 45780V102. A total of 35 filers reported holding INOTEK PHARMACEUTICALS CORP in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $359,000 | -12.4% | 201,509 | -6.7% | 0.00% | 0.0% |
| Q2 2017 | $410,000 | +100.0% | 215,882 | +110.8% | 0.00% | – |
| Q1 2017 | $205,000 | -94.5% | 102,428 | -83.2% | 0.00% | -100.0% |
| Q4 2016 | $3,719,000 | +9.6% | 609,781 | +70.4% | 0.01% | +33.3% |
| Q3 2016 | $3,392,000 | +230.3% | 357,788 | +159.1% | 0.01% | +200.0% |
| Q2 2016 | $1,027,000 | +276.2% | 138,066 | +274.2% | 0.00% | +100.0% |
| Q1 2016 | $273,000 | +38.6% | 36,892 | +111.9% | 0.00% | – |
| Q4 2015 | $197,000 | – | 17,412 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|